![Nonstandard and adjunctive medical therapies for systemic lupus erythematosus - McMurray - 2001 - Arthritis Care & Research - Wiley Online Library Nonstandard and adjunctive medical therapies for systemic lupus erythematosus - McMurray - 2001 - Arthritis Care & Research - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/b678ab5b-ba85-4fe4-af19-526f089475e2/acr.v75.3.cover.jpg?trick=1678455442703)
Nonstandard and adjunctive medical therapies for systemic lupus erythematosus - McMurray - 2001 - Arthritis Care & Research - Wiley Online Library
![Cureus | A Case of Acute Granulomatous Conjunctivitis Caused by Cat-transmitted Sporothrix schenckii | Article Cureus | A Case of Acute Granulomatous Conjunctivitis Caused by Cat-transmitted Sporothrix schenckii | Article](https://assets.cureus.com/uploads/figure/file/46528/lightbox_e2e17db0b9c311e8b151454e90817d85-Figure-1.png)
Cureus | A Case of Acute Granulomatous Conjunctivitis Caused by Cat-transmitted Sporothrix schenckii | Article
![Frontiers | Thrombosis and Inflammation—A Dynamic Interplay and the Role of Glycosaminoglycans and Activated Protein C Frontiers | Thrombosis and Inflammation—A Dynamic Interplay and the Role of Glycosaminoglycans and Activated Protein C](https://www.frontiersin.org/files/Articles/866751/fcvm-09-866751-HTML-r1/image_m/fcvm-09-866751-g001.jpg)
Frontiers | Thrombosis and Inflammation—A Dynamic Interplay and the Role of Glycosaminoglycans and Activated Protein C
T sejtek és kemokinek változásának vizsgálata SLE pulmonalis manifesztációjában Doktori értekezés Dr.Vincze Krisztina
![COVID-19 Breaking News! French Study Confirms Previous Coronavirus Immunity Offers No Protection Against SARS-CoV-2 - Thailand Medical News COVID-19 Breaking News! French Study Confirms Previous Coronavirus Immunity Offers No Protection Against SARS-CoV-2 - Thailand Medical News](https://www.thailandmedical.news/uploads/news/5f3b22721a33d_COVID-19-Breaking-News.jpg)
COVID-19 Breaking News! French Study Confirms Previous Coronavirus Immunity Offers No Protection Against SARS-CoV-2 - Thailand Medical News
![PDF) Clinical and laboratory characteristics of Brazilian versus non-Brazilian primary antiphospholipid syndrome patients in AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking (APS ACTION) clinical database and repository PDF) Clinical and laboratory characteristics of Brazilian versus non-Brazilian primary antiphospholipid syndrome patients in AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking (APS ACTION) clinical database and repository](https://i1.rgstatic.net/publication/355751953_Clinical_and_laboratory_characteristics_of_Brazilian_versus_non-Brazilian_primary_antiphospholipid_syndrome_patients_in_AntiPhospholipid_Syndrome_Alliance_for_Clinical_Trials_and_InternatiOnal_Network/links/617c135a0be8ec17a946e675/largepreview.png)
PDF) Clinical and laboratory characteristics of Brazilian versus non-Brazilian primary antiphospholipid syndrome patients in AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking (APS ACTION) clinical database and repository
![Blog: ALS vs MS vs Parkinson's Disease: The Differences Between Three Common Neurodegenerative Diseases | ALS Therapy Development Institute Blog: ALS vs MS vs Parkinson's Disease: The Differences Between Three Common Neurodegenerative Diseases | ALS Therapy Development Institute](https://www.als.net/images/blog//2020/Neuron_B01_01_1_3_Merge_adj.jpg)
Blog: ALS vs MS vs Parkinson's Disease: The Differences Between Three Common Neurodegenerative Diseases | ALS Therapy Development Institute
![Frontiers | Genetic Polymorphisms and the Clinical Response to Systemic Lupus Erythematosus Treatment Towards Personalized Medicine Frontiers | Genetic Polymorphisms and the Clinical Response to Systemic Lupus Erythematosus Treatment Towards Personalized Medicine](https://www.frontiersin.org/files/Articles/820927/fphar-13-820927-HTML-r1/image_m/fphar-13-820927-g003.jpg)